Back to Authors

Weinshenker, Brian G

0000-0001-5806-6203

Mayo Clinic

From the Department of Neurology (S.S.S., M.B., D.T., B.G.W., S.J.P., E.P.F., M.T.B., J.J.C.), and Center for Multiple Sclerosis and Autoimmune Neurology (S.S.S., M.B., D.M.W., B.G.W., S.J.P., E.P.F., J.J.C.), Mayo Clinic, Rochester, MN; Department of Neur

Citations 140

Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG–associated disorders (MOGAD)?

Neurology | December 12, 2019 | Volume: 94 | Issue: 2 | Pages: 85-88

10.1212/wnl.0000000000008786 | PMID 31827002

Unilateral motor progression in MS

Neurology | July 10, 2019 | Volume: 93 | Issue: 7 | Pages: No page available

10.1212/wnl.0000000000007944 | PMID 31289142

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology

Neurology | June 25, 2019 | Volume: 93 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000007828 | PMID 31235660

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

Brain | May 13, 2019 | Volume: 142 | Issue: 7 | Pages: 1858-1875

10.1093/brain/awz144 | PMID 31209474

Abstract MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some diseases, now recognized as conditions distinct from multiple sclerosis, may satisfy the MRI criteria for multiple sclerosis (e.g. neuromyelitis optica spectrum disorders, Susac syndrome), thus making the diagnosis of multiple sclerosis more challenging, especially if biomarker testing (such as serum anti-AQP4 antibodies) is not informative. Improvements in MRI technology contribute and promise to better define the typical features of multiple sclerosis lesions (e.g. juxtacortical and periventricular location, cortical involvement). Greater understanding of some key aspects of multiple sclerosis pathobiology has allowed the identification of characteristics more specific to multiple sclerosis (e.g. central vein sign, subpial demyelination and lesional rims), which are not included in the current multiple sclerosis diagnostic criteria. In this review, we provide the clinicians and researchers with a practical guide to enhance the proper recognition of multiple sclerosis lesions, including a thorough definition and illustration of typical MRI features, as well as a discussion of red flags suggestive of alternative diagnoses. We also discuss the possible place of emerging qualitative features of lesions which may become important in the near future.
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders

Brain | March 6, 2019 | Volume: 142 | Issue: 5 | Pages: 1310-1323

10.1093/brain/awz054 | PMID 30938427

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody

JAMA Neurology | December 21, 2018 | Volume: 76 | Issue: 3 | Pages: 301

10.1001/jamaneurol.2018.4053 | PMID 30575890

Area postrema syndrome

Neurology | September 26, 2018 | Volume: 91 | Issue: 17 | Pages: No page available

10.1212/wnl.0000000000006392 | PMID 30258024

Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria

JAMA Neurology | September 25, 2018 | Volume: 76 | Issue: 1 | Pages: 56

10.1001/jamaneurol.2018.2734 | PMID 30264146

Population-based study of “no evident disease activity” in MS

Neurology Neuroimmunology & Neuroinflammation | September 11, 2018 | Volume: 5 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000495 | PMID 30211251

DNA Compression Caused by an Upstream Point Mutation

BioTechniques | August 15, 2018 | Volume: 25 | Issue: 1 | Pages: 68-72

10.2144/98251st01 | PMID 9668978